Skip to content
DraconiticResearch
Search Sources API
220,472 studies31 sourcesUpdated 29 min ago

Oncology

5,770 studies495 in 7 days2,675 in 30 days

Filters
Type
Date
Clear

Latest

5,770 studies

  1. Neuroblastoma-derived Extracellular Vesicles Disrupt the Integrity of Central Nervous System Barriers via Tight Junction Modulation
    T. Manko, I. Luz, M. Zorsky +5
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  2. FANCM restrains structural genome evolution and defines a synthetic lethal dependency in BRCA1-deficient breast cancer
    A. Panday, F. Ramadan, S. B. Shah +9
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  3. Preclinical trial supports dual inhibition of BCL2 and Aurora kinase A for MYCN-amplified high-risk neuroblastoma
    A. Kamili, B. A. Hearn, I. Temelkoska +21
    bioRxivPreprintCC BYFull textOncologybioRxiv
  4. An RGS5-positive fibroblast to WNT-like epithelial TGFB axis in colorectal liver metastasis, replicated in an independent paired cohort
    Y. Yu, F. Ma, Y. Yu
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  5. Quantitative and sensitive neuroblastoma minimal residual disease detection using extrachromosomal DNA (ecDNA) breakpoints
    A. Szymansky, F. Hertwig, A. Winkler +25
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  6. Deep Learning-based Modeling Enhances Efficacy of Natural Ligand CAR Binders Targeting CD70
    A. S. Kang, R. Dalal, M. Li +22
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  7. Melittin-induced membrane disruption in hepatocellular carcinoma involves mtROS/GSDME-mediated pyroptosis
    H. Zang, M. Lu, N. Fan +4
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  8. SUMOylation is a Therapeutic Vulnerability in High-risk Neuroblastoma
    A. Kukkula, S. Sriraman, V. Virtanen +5
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  9. Stochastic Boolean Model of Death Signaling in MCF7:5C Predicts Cell Death Inducers and Inhibitors
    K. Taoma, T. Laomettachit, S. Sengupta +3
    bioRxivPreprintCC BYFull textOncologybioRxiv
  10. Loss of short-form Ron promotes B and T cell cooperation to prevent outgrowth of breast cancer bone metastasis
    C. H. Valencia, M. Nadjsombati, T. Pham +4
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  11. The small molecule inhibitor SU056-mediated targeting of YB1 inhibits the Rb pathway in triple-negative breast cancer tumors
    W. Wang, Y. Kim, X. Zhao +4
    bioRxivPreprintPublic domainFull textOncologybioRxiv
  12. Targeting FEN1 disrupts EIF4A3-mediated MUC1-C autoregulation: a novel strategy to suppress lung adenocarcinoma progression.
    Min Wu, Benmeng Wu, Xuebing Yan +7
    Cell death & diseasePeer-reviewedCC BYFull textOncologyEurope PMC
  13. Involvement of Protein Kinase C Delta and Monocarboxylate Transporter 4 in the Development of Statin-Induced Cytotoxicity in a Rhabdomyosarcoma-Derived Cell Line
    Keisuke Okamoto, Toya Matsui, Yurika Kikutani +4
    Biological and Pharmaceutical BulletinPeer-reviewedCC BY-NCFull textOncologyJ-STAGE
  14. Exploring patient perspectives of exercise in advanced pancreatic cancer care in Canada: A qualitative interpretive description
    Chloe Cyr, Ben Perry, Ravi Ramjeesingh +2
    Palliative & Supportive CarePeer-reviewedCC BY 4.0Full textOncologyPMC
  15. Activation of PP2A-B56α leads to aberrant EGFR signaling and proliferative phenotypes in PDAC
    Claire M. Pfeffer, Sydney J. Clifford, Saadia A. Karim +19
    Molecular cancer therapeuticsPeer-reviewedLicence not statedFull textOncologyPMC
  16. An Oxidative Stress-Associated Seven-Gene Prognostic Signature in Lung Adenocarcinoma: Integrative Transcriptomic Analysis Across Public Cohorts
    X. Zhou, Z. Le, P. Song +6
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  17. Interplay of NuA4/TIP60 and PRC2 Complex Activities in Fusion Driven Endometrial Stromal Sarcoma
    D. Sudarshan, C. Joly-Beauparlant, S. Bianco +11
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  18. G-quadruplex targeting by CX-5461 as a novel therapeutic strategy in testicular germ cell tumors
    R. Islam, A. Liesen, C. S. R. Roque +2
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  19. HUMAN-LIKE SIALOME REMODELING LINKS HYPERGLYCEMIA TO COLORECTAL CANCER PROGRESSION
    R. C. M. Santos, G. S. Ferreira, A. L. Lopes +10
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  20. Tumor-derived SAA1-TLR4 signaling drives tumor-to-muscle communication in pancreatic cancer cachexia
    G. Guarnaccia, J. Massenet, A. Cecchini +24
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  21. Stepwise bladder carcinogenesis reveals transcriptional reprogramming involving MMP1 and COL7A1
    Y. Nagashima, M. Elbadawy, Y. Naito +5
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  22. Spatial multi-omics resolve epithelium-fibroblast gradients and highlight NESTIN-NOTCH1-expressing subepithelial fibroblasts during human pancreatic tumorigenesis
    M. Batardiere, M. I. Ibanez-Rios, A. Khellaf +25
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  23. Genetic and structural interpretation of NLRP1 FIIND domain variants in glioma in an Indian cohort: a pilot study
    S. Chhipa, O. A. Sonawane, M. Revanth +7
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  24. Co-translational O-glycosylation driven by GALNTs spatial reprogramming fosters pancreatic cancer growth
    R. Bennion, E. Lohman, G. Del Rio +13
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  25. Targeting fibroblast activation suppresses chemotherapy-induced pro-invasive remodeling of the extracellular matrix
    A. Yui, L. Peng, K. C. Lew +12
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv